Unichem Laboratories · NSE: UNICHEMLAB · BSE: 506690
Q2 FY21 results · Jul–Sep 2020
Unichem Laboratories reported revenue from operations of ₹317.51 crore (up 7.4% from Q2 FY20) and net profit of ₹8.74 crore for Q2 FY21 (Jul–Sep 2020), on a consolidated basis.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 317.51 | 295.61 | +7.4% | 317.27 | +0.1% |
| Other income | 10.04 | 28.13 | −64.3% | 16.71 | −39.9% |
| Total income | 327.55 | 323.74 | +1.2% | 333.98 | −1.9% |
| Profit before share of associates & JVs and tax | 17.98 | (21.51) | Turned profit | 7.00 | +156.8% |
| Share of profit/(loss) of associates & JVs | 0.00 | (0.02) | 0.04 | ||
| Net profit for the period | 8.74 | (22.21) | Turned profit | 2.43 | +258.9% |
| EPS, basic (₹) | 1.24 | (3.15) | Turned profit | 0.35 | +254.3% |
| Net margin (%) | 2.8 | -7.5 | 0.8 |
This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.
| Item | Q2 FY21 | Q2 FY20 | YoY | Q1 FY21 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 310.93 | 225.10 | +38.1% | 240.77 | +29.1% |
| Other income | 10.41 | 29.05 | −64.2% | 18.73 | −44.4% |
| Total income | 321.34 | 254.15 | +26.4% | 259.50 | +23.8% |
| Profit before tax | 35.16 | (24.86) | Turned profit | (7.55) | Turned profit |
| Net profit for the period | 30.34 | (24.86) | Turned profit | (7.55) | Turned profit |
| EPS, basic (₹) | 4.31 | (7.06) | Turned profit | (1.07) | Turned profit |
| Net margin (%) | 9.8 | -11.0 | -3.1 |
Consolidated
- Filed with BSE
- 06 Nov 2020, 11:45 IST
- Board meeting
- 31 Oct 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Nov 2020, 11:45 IST
- Board meeting
- 31 Oct 2020
- Period
- 01 Jul 2020 to 30 Sep 2020
- Review status
- Unaudited
- Source
- XBRL filing on BSE